Laparoscopic Surgical Treatment of Abdominal Aortic Aneurysms and Aorto-iliac Occlusive Disease (LAS)
Abdominal Aortic Aneurysm
Aorto-iliac Occlusive Disease
|Study Design:||Observational Model: Cohort
Time Perspective: Prospective
|Official Title:||Laparoscopic Aortic Surgery: Norwegian Experiance|
- No residual symptoms of claudication intermittent among patients with aorto-iliac occlusive disease and no residual or recurrent aneurysm among patients operated for AAA one year post-operatively [ Time Frame: 2011-2020 ] [ Designated as safety issue: Yes ]
- All cause mortality per- and post-operatively [ Time Frame: 2011-2020 ] [ Designated as safety issue: Yes ]
|Study Start Date:||September 2010|
|Estimated Study Completion Date:||September 2020|
|Estimated Primary Completion Date:||September 2015 (Final data collection date for primary outcome measure)|
Patients with abdominal aortic aneurysms with an anterioposterior or transverse diameter of atleast 55 mm and also patients with an aorto-iliac occlusive disease (Type TASC-D) will be offered a totally laparoscopic operation.
Patients operated with conventional open surgery shall be included as a control group.
Operative data and post-operative outcomes (Morbidity and mortality, etc)shall be registered prospectively. Besides short form- 36 (SF-36) shall be used for the evaluation of patients health related quality of life, preoperatively,1,3,and 6 months and 1 year post-operatively.
Please refer to this study by its ClinicalTrials.gov identifier: NCT01259908
|Contact: Syed Sajid Hussain Kazmi, MD, PhDfirstname.lastname@example.org|
|Oslo University Hospital||Recruiting|
|Oslo, Norway, 0424|
|Contact: Syed Sajid Hussain Kazmi, MD +47 22894000 email@example.com|